Literature DB >> 14625779

Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.

Jolijn Brouwer1, Evelien J Bodar, Remco De Bree, Johannes A Langendijk, Jonas A Castelijns, Otto S Hoekstra, C René Leemans.   

Abstract

Detecting recurrent laryngeal carcinoma after radiotherapy for a primary tumour can be difficult. Early detection however, is an important prognostic factor. Although a biopsy should be performed in case of clinical suspicion, repeated negative biopsies do not exclude the presence of viable tumour. The trauma caused by biopsies in irradiated tissue may initiate infection, further oedema and failure to heal. We investigated these problems and evaluated the current care and its usefulness. A survey of the current practice concerning diagnostic procedures for detecting recurrent laryngeal carcinoma after radiotherapy in the major institutions treating head and neck cancer in The Netherlands was performed by means of a questionnaire. Furthermore, we performed a comprehensive analysis of the extent and yield of diagnostic work-up in a cohort of patients clinically suspected of a recurrence, who had undergone direct laryngoscopy between 1986 and 1998 in our institution, with a follow-up of at least 6 months. In case of suspected recurrence, 94% of the departments use direct laryngoscopy under general anaesthesia with the taking of biopsies as a diagnostic technique. Imaging does not play an important role. In our department 207 laryngoscopies were evaluated in 131 patients. In 70 patients the first laryngoscopy was negative. Of these initial negative laryngoscopies, 22 (31%) turned out to be false negative within 6 months. Thirty-seven patients remained disease free. They underwent 65 unnecessary laryngoscopies to come to this conclusion. In the decision to perform direct laryngoscopy, the conventional work up leaves room for improvement. Too many unnecessary laryngoscopies are performed. New imaging techniques such as FDG-PET or new applications of CT or MRI may improve the yield of direct laryngoscopy.

Entities:  

Mesh:

Year:  2003        PMID: 14625779     DOI: 10.1007/s00405-003-0708-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

Review 1.  Imaging of laryngeal cancer.

Authors:  J A Castelijns; R Hermans; M W van den Brekel; S K Mukherji
Journal:  Semin Ultrasound CT MR       Date:  1998-12       Impact factor: 1.875

2.  T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage.

Authors:  J T Parsons; W M Mendenhall; S P Stringer; N J Cassisi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

3.  Partial laryngectomy for glottic cancer after high-dose radiotherapy.

Authors:  R S Lavey; T C Calcaterra
Journal:  Am J Surg       Date:  1991-10       Impact factor: 2.565

4.  Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.

Authors:  K M Greven; D W Williams; J W Keyes; W F McGuirt; N E Watson; M E Randall; M Raben; K R Geisinger; J O Cappellari
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

Review 5.  T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results.

Authors:  C H Terhaard; G J Hordijk; P van den Broek; P C de Jong; G B Snow; F J Hilgers; B A Annyas; R E Tjho-Heslinga; J M de Jong
Journal:  Clin Otolaryngol Allied Sci       Date:  1992-10

6.  Glottic cancer. Surgical salvage for radiation failure.

Authors:  A J Fisher; D D Caldarelli; D C Chacko; L D Holinger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1986-05

7.  The enigma of post-radiation oedema and residual or recurrent carcinoma of the larynx and pyriform fossa.

Authors:  S Bahadur; R C Amatya; S K Kacker
Journal:  J Laryngol Otol       Date:  1985-08       Impact factor: 1.469

8.  Hemilaryngectomy for glottic carcinoma after radiation therapy failure.

Authors:  J M DelGaudio; D J Fleming; R M Esclamado; W R Carroll; C R Bradford
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-09

9.  Imaging modalities in recurrent head and neck tumors.

Authors:  G S Gussack; P A Hudgins
Journal:  Laryngoscope       Date:  1991-02       Impact factor: 3.325

10.  Positron emission tomography in the detection of residual laryngeal carcinoma.

Authors:  J R Austin; F C Wong; E E Kim
Journal:  Otolaryngol Head Neck Surg       Date:  1995-10       Impact factor: 5.591

View more
  14 in total

1.  US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions.

Authors:  Lorenzo Preda; Elvio De Fiori; Cristiano Rampinelli; Mohssen Ansarin; Giuseppe Petralia; Fausto Maffini; Daniela Alterio; Luke Bonello; Fausto Chiesa; Massimo Bellomi
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

2.  Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Authors:  Peter Zbären; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503

Review 3.  Assessment of treatment response after chemoradiation of head and neck cancer.

Authors:  Fernando Luiz Dias
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

4.  Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.

Authors:  Dechen W Tshering Vogel; Peter Zbaeren; Andreas Geretschlaeger; Peter Vermathen; Frederik De Keyzer; Harriet C Thoeny
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

5.  Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications.

Authors:  Nicolas Fakhry; David Lussato; Thierry Jacob; Roch Giorgi; Antoine Giovanni; Michel Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-04       Impact factor: 3.236

6.  Chondronecrosis versus recurrence: FDG PET/CT solves the dilemma in a case of locally advanced laryngeal cancer treated with definitive radiotherapy.

Authors:  Ameya D Puranik; Nilendu C Purandare; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2013-07

7.  The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.

Authors:  Addy C G van Hooren; Jolijn Brouwer; Remco de Bree; Otto S Hoekstra; C René Leemans; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-29       Impact factor: 2.503

8.  Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients?

Authors:  Tarun Kumar Jain; Guman Singh; Sumit Goyal; Ajay Yadav; Dinesh Yadav; Nitin Khunteta; Hemant Malhotra
Journal:  World J Nucl Med       Date:  2021-02-12

Review 9.  Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Authors:  Nam P Nguyen; Alexander Chi; Michael Betz; Fabio Almeida; Paul Vos; Rick Davis; Benjamin Slane; Misty Ceizyk; Dave Abraham; Lexie Smith-Raymond; Michelle Stevie; Siyoung Jang; Steven Gelumbauskas; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.

Authors:  L van der Putten; O S Hoekstra; R de Bree; D J Kuik; E F I Comans; J A Langendijk; C R Leemans
Journal:  Mol Imaging Biol       Date:  2008-07-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.